富祥药业
(300497)
| 流通市值：61.72亿 | | | 总市值：75.41亿 |
| 流通股本：4.41亿 | | | 总股本：5.39亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 632,736,892.59 | 606,508,100.18 | 640,527,457.38 | 695,350,502.08 |
| 交易性金融资产 | 1,978,000 | 2,185,000 | 2,185,000 | 2,185,000 |
| 应收票据及应收账款 | 295,970,799.01 | 279,800,662.04 | 269,790,821.62 | 304,021,769.99 |
| 其中：应收票据 | 24,490,274.82 | 27,664,255.58 | 34,940,540.14 | 42,783,498.32 |
| 应收账款 | 271,480,524.19 | 252,136,406.46 | 234,850,281.48 | 261,238,271.67 |
| 应收款项融资 | 124,067,621.11 | 165,605,297.04 | 175,786,401.09 | 194,141,196.88 |
| 预付款项 | 18,884,654.5 | 8,120,775.1 | 16,337,318.08 | 10,419,901.2 |
| 其他应收款合计 | 11,222,516.88 | 12,665,071.11 | 17,110,793.48 | 28,029,363.75 |
| 存货 | 406,039,083.61 | 471,593,590.6 | 444,529,748.42 | 421,053,194.07 |
| 其他流动资产 | 33,472,346.33 | 31,771,711.24 | 29,220,362.74 | 25,822,478.25 |
| 流动资产合计 | 1,524,371,914.03 | 1,578,250,207.31 | 1,595,487,902.81 | 1,681,023,406.22 |
| 非流动资产: | | | | |
| 长期股权投资 | 21,809,362.98 | 21,809,362.98 | 23,702,696.63 | 23,702,696.63 |
| 其他权益工具投资 | 150,994,909.7 | 150,994,909.7 | 150,994,909.7 | 150,994,909.7 |
| 其他非流动金融资产 | 78,383,367.2 | 78,383,367.2 | 80,524,400.58 | 81,198,734.97 |
| 投资性房地产 | 31,523,993.43 | 32,047,941.81 | 32,571,890.19 | 33,095,838.57 |
| 固定资产 | 1,684,389,636.03 | 1,726,260,522.59 | 1,768,778,905.32 | 1,808,896,905.72 |
| 在建工程 | 596,988,099.81 | 530,205,061.31 | 518,161,139.34 | 457,857,156.07 |
| 无形资产 | 289,309,175.33 | 291,159,341.46 | 293,107,332.95 | 235,000,218.09 |
| 递延所得税资产 | 31,099,535.07 | 29,985,692.69 | 30,810,549.5 | 37,255,211.34 |
| 其他非流动资产 | 29,029,045.39 | 42,834,641.17 | 29,339,167.47 | 27,851,058.51 |
| 非流动资产合计 | 2,913,527,124.94 | 2,903,680,840.91 | 2,927,990,991.68 | 2,855,852,729.6 |
| 资产总计 | 4,437,899,038.97 | 4,481,931,048.22 | 4,523,478,894.49 | 4,536,876,135.82 |
| 流动负债: | | | | |
| 短期借款 | 631,385,972.22 | 591,398,333.33 | 596,406,006.94 | 556,398,323.61 |
| 应付票据及应付账款 | 384,372,047.24 | 443,469,979.35 | 519,610,623.45 | 603,370,646.16 |
| 其中：应付票据 | 186,085,994.51 | 233,495,370.37 | 256,863,401.32 | 318,642,140.66 |
| 应付账款 | 198,286,052.73 | 209,974,608.98 | 262,747,222.13 | 284,728,505.5 |
| 预收款项 | 236,744.22 | 426,320.54 | 183,781.58 | 486,690.12 |
| 合同负债 | 3,049,936.43 | 2,224,471.22 | 2,332,741.67 | 2,231,456.63 |
| 应付职工薪酬 | 15,823,582.39 | 13,382,663.32 | 13,466,984.35 | 24,734,729.06 |
| 应交税费 | 10,686,086.38 | 8,609,453.89 | 6,786,618.06 | 5,716,174.83 |
| 其他应付款合计 | 5,352,842.22 | 6,131,911.54 | 7,794,570.67 | 14,915,339.28 |
| 一年内到期的非流动负债 | 260,900,000 | 260,900,000 | 416,780,000 | 311,780,000 |
| 其他流动负债 | 19,894,888.48 | 22,644,631.79 | 24,905,801.39 | 24,193,131.17 |
| 流动负债合计 | 1,331,702,099.58 | 1,349,187,764.98 | 1,588,267,128.11 | 1,543,826,490.86 |
| 非流动负债: | | | | |
| 长期借款 | 829,474,000 | 830,474,000 | 631,484,000 | 736,484,000 |
| 递延收益 | 106,886,525.7 | 104,403,968 | 103,034,993.9 | 77,670,570.44 |
| 递延所得税负债 | 1,886,570.1 | 1,910,290.7 | 1,934,011.31 | 1,957,731.92 |
| 非流动负债合计 | 938,247,095.8 | 936,788,258.7 | 736,453,005.21 | 816,112,302.36 |
| 负债合计 | 2,269,949,195.38 | 2,285,976,023.68 | 2,324,720,133.32 | 2,359,938,793.22 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 538,648,934 | 550,004,834 | 550,004,834 | 550,004,834 |
| 资本公积 | 1,247,068,457.73 | 1,381,102,767.24 | 1,381,102,767.24 | 1,381,102,767.24 |
| 减:库存股 | - | 174,858,651.95 | 174,858,651.95 | 174,858,651.95 |
| 其他综合收益 | 15,244,673.25 | 15,244,673.25 | 15,244,673.25 | 15,244,673.25 |
| 专项储备 | 1,572,845.33 | 1,354,597.47 | 413,206.16 | 201,082.06 |
| 盈余公积 | 144,261,996.51 | 144,261,996.51 | 144,261,996.51 | 144,261,996.51 |
| 未分配利润 | 201,764,418.36 | 257,604,793.78 | 266,754,756.42 | 264,515,944.43 |
| 归属于母公司股东权益合计 | 2,148,561,325.18 | 2,174,715,010.3 | 2,182,923,581.63 | 2,180,472,645.54 |
| 少数股东权益 | 19,388,518.41 | 21,240,014.24 | 15,835,179.54 | -3,535,302.94 |
| 股东权益合计 | 2,167,949,843.59 | 2,195,955,024.54 | 2,198,758,761.17 | 2,176,937,342.6 |
| 负债和股东权益合计 | 4,437,899,038.97 | 4,481,931,048.22 | 4,523,478,894.49 | 4,536,876,135.82 |
| 公告日期 | 2025-10-28 | 2025-08-27 | 2025-04-26 | 2025-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |